Fundamentals Hub
ACTU ACTUATE THERAPEUTICS, INC.
ACTU financial statements, revenue, balance sheet, cash flow, and SEC filings
Showing 3 of 3 annual and 0 of 12 quarterly periods.
Full history available with a free account or via API.
▼ Company Profile
Filer Category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity Type
Operating
Public Float
$42.10M (Jun 2025)
Industry (SIC)
2834 Pharmaceutical Preparations
Incorporated
DE
Fiscal Year End
December (1231)
Phone
847-986-4190
EIN
473044785
Headquarters
FORT WORTH, TX, 76107
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
▼ Key Metrics (TTM)
As of Jun 30, 2026Financials
Revenue
-
Net Income
$-20.45M
Total Assets
$5.20M
Total Equity
$989.15K
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
-2067.8%
Return on Assets
-393.4%
Current Ratio
1.25x
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| OPERATING EXPENSES | |||
| R&D Expense | $10.29M | $18.68M | $21.71M |
| SG&A Expense | $12.20M | $6.48M | $3.27M |
| Operating Income | $-22.50M | $-25.16M | $-24.97M |
| NON-OPERATING INCOME / EXPENSE | |||
| Interest Income | $287.71K | $222.29K | $352.67K |
| Other Income/Expense | $267.46K | $-2.12M | $229.21K |
| Income Tax | $800 | $800 | $0 |
| Net Income | $-22.23M | $-27.29M | $-24.74M |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $-1.06 | $-3.26 | $-17.24 |
| Diluted Shares | 21.02M | 8.37M | 1.43M |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $13.16M | $8.64M | $2.96M |
| Other Current Assets | $484.00K | $566.28K | $36.91K |
| Current Assets | $13.64M | $9.21M | $3.00M |
| Other Noncurrent Assets | $392.49K | $110.55K | $0 |
| Noncurrent Assets | $392.49K | $110.55K | $0 |
| Total Assets | $14.04M | $9.32M | $3.00M |
| LIABILITIES | |||
| Accounts Payable | $1.52M | $1.92M | $3.42M |
| Other Current Liabilities | $3.57M | $5.92M | $3.22M |
| Current Liabilities | $5.71M | $8.80M | $6.92M |
| Noncurrent Liabilities | $404.99K | $411.76K | $1.52M |
| Total Liabilities | $6.11M | $9.21M | $8.44M |
| EQUITY | |||
| Common Stock | $23 | $20 | $2 |
| Additional Paid-in Capital | $162.53M | $132.48M | $5.47M |
| Retained Earnings | $-154.61M | $-132.38M | $-105.09M |
| Total Equity | $7.92M | $104.19K | $-99.63M |
| Temporary Equity | - | $0 | $94.18M |
| Total Liabilities & Equity | $14.04M | $9.32M | $3.00M |
| SUPPLEMENTAL | |||
| Shares Outstanding | 23.25M | 19.53M | 1.69M |
| Check: A − (L + E + Temp. Equity) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-19.21M | $-21.84M | $-21.63M |
| Capital Expenditures | - | - | - |
| Cash from Investing | $0 | $0 | $0 |
| Cash from Financing | $23.72M | $27.53M | $4.13M |
| Free Cash Flow | - | - | - |
| Beginning Cash (CFS) | $8.64M | $2.96M | $20.45M |
| Net Change in Cash | $4.52M | $5.68M | $-17.49M |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | $13.16M | $8.64M | $2.96M |
| Cash per BS | $13.16M | $8.64M | $2.96M |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $13.16M | $8.64M | $2.96M |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
Is ACTUATE THERAPEUTICS, INC. profitable?
No. ACTUATE THERAPEUTICS, INC. reported $-20.45M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.